Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New digital program aims to curb drug use and unplanned pregnancies in Justice-Involved women

NCT ID NCT06889831

Disease control Sponsor: Fairleigh Dickinson University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital group program called WORTH Paths for women aged 18-44 who have been involved in the criminal legal system, have a substance use disorder, and need contraception but aren't using it. The program includes three virtual group sessions with interactive activities to help reduce drug use and increase contraceptive use. Fifty participants will be randomly assigned to either the WORTH Paths program or a general wellness group, and researchers will track changes over three months using surveys and urine tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WORTH Paths digital intervention (behavioral group sessions via videoconference with digital activities)
What this could lead to
If successful, this could provide a scalable, accessible way to help women in the criminal legal system reduce drug use and prevent unintended pregnancies.
What could go wrong
This is a small early feasibility study with only 50 participants, so results may not apply broadly. The intervention is behavioral and relies on self-report and urine tests, which may have limitations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female sex at birth * Aged 18-44 years * Past year criminal legal involvement (e.g., incarceration or community supervision) * Meets criteria for current substance use disorder (SUD) as defined by DSM-5 and assessed by the Mini-International Neuropsychiatric Interview (MINI) * Meets criteria for unmet need for contraception (capable of pregnancy, sexually active, does not want to become pregnant within the next year, but is currently not using contraception) * Able to read, write, and speak English * Willing and able to provide informed consent Exclusion Criteria: * Currently pregnant or actively trying to conceive * Diagnosed infertility (e.g., menopause, tubal ligation, hysterectomy) * Unable to provide informed consent due to significant cognitive impairment, mental health condition, or substance intoxication * Unable or unwilling to meet study requirements (e.g., attend sessions, complete assessments)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sexual and reproductive health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Coitus substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sexual and reproductive health Sexual risk behavior Substance use disorder (SUD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Fairleigh Dickinson University

    RECRUITING

    Teaneck, New Jersey, 07666, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.